208 related articles for article (PubMed ID: 4965290)
1. Leriche syndrome in a patient with prolonged and continuous use of ergot derivatives. A review of the vascular effects of ergot.
Pader E
Vasc Dis; 1967 Dec; 4(6):380-8. PubMed ID: 4965290
[No Abstract] [Full Text] [Related]
2. [Therapy of migraine].
Dieckmann H
Dtsch Med Wochenschr; 1968 Dec; 93(50):2444-6. PubMed ID: 4972428
[No Abstract] [Full Text] [Related]
3. [Therapy of migraine with special reference to ergot alkaloids].
Mumenthaler-Dejung M
Wien Med Wochenschr; 1994; 144(5-6):108-9. PubMed ID: 8053214
[TBL] [Abstract][Full Text] [Related]
4. [Greater value of sumatriptan over ergot alkaloids still not proven].
van Luijn JC
Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2554-8. PubMed ID: 8272145
[No Abstract] [Full Text] [Related]
5. Some new vascular and biochemical aspects of the mechanism of action of ergot compounds.
Berde B
Headache; 1972 Jan; 11(4):139-47. PubMed ID: 4400045
[No Abstract] [Full Text] [Related]
6. Teratogen update: ergot and ergotamine.
Raymond GV
Teratology; 1995 May; 51(5):344-7. PubMed ID: 7482356
[TBL] [Abstract][Full Text] [Related]
7. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
[No Abstract] [Full Text] [Related]
8. Drugs for migraine.
Treat Guidel Med Lett; 2011 Feb; 9(102):7-12; quiz 14. PubMed ID: 21304447
[No Abstract] [Full Text] [Related]
9. Use of ergot preparations in acute migraine attacks.
Dalessio DJ
Headache; 1981 Mar; 21(2):75. PubMed ID: 7239904
[No Abstract] [Full Text] [Related]
10. [Ergotamine-induced disorders, past and present. From St. Anthony's fire to adverse effects of drugs].
Schramm A; Sperling M
MMW Munch Med Wochenschr; 1983 Jun; 125(23):492-4. PubMed ID: 6410212
[No Abstract] [Full Text] [Related]
11. [Treatment of maniacal syndromes by dihydrogenated alkaloids of ergot of rye (hydergine) associated with electroshock].
POSTEL J; COSSA P; BERNUY M
Ann Med Psychol (Paris); 1956 Jun; 114(1):75-80. PubMed ID: 13340372
[No Abstract] [Full Text] [Related]
12. [Migraine].
Heyck H
Med Klin; 1968 Aug; 63(35):1401-2. PubMed ID: 5693127
[No Abstract] [Full Text] [Related]
13. Ergotism associated with the treatment of migraine headaches.
Najib A; Stallworth JM; Groom D
J S C Med Assoc; 1966 Nov; 62(11):424-6. PubMed ID: 5232174
[No Abstract] [Full Text] [Related]
14. [Treatment of migraine attacks].
Pradalier A; Baudesson G; Delage A
Pathol Biol (Paris); 2000 Sep; 48(7):679-89. PubMed ID: 11072648
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of migraine (author's transl)].
Mumenthaler M
Ther Umsch; 1974 Nov; 31(11):797-803. PubMed ID: 4139778
[No Abstract] [Full Text] [Related]
16. Experiences with hydergine in peripheral vascular disorders.
CAITHAML W
Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1954; 278(4):396-408. PubMed ID: 13213192
[No Abstract] [Full Text] [Related]
17. Guidelines and recommendations for the treatment of migraine. Italian Society for the Study of Headache (SISC).
Funct Neurol; 1993; 8(6):441-6. PubMed ID: 8150324
[No Abstract] [Full Text] [Related]
18. The hydrogenated alkaloids of ergot (hydergine) in geriatrics; follow-up study.
POPKIN RJ
Am Pract Dig Treat; 1956 Oct; 7(10):1594-7. PubMed ID: 13362833
[No Abstract] [Full Text] [Related]
19. Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine.
GRAHAM JR
N Engl J Med; 1954 Jun; 250(22):936-8. PubMed ID: 13165929
[No Abstract] [Full Text] [Related]
20. Ramifications of ergot research and their impact of the treatment of migraine.
Cerletti A
Arch Neurobiol (Madr); 1974; 37 SUPPL():3-8. PubMed ID: 4462486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
